(P10-034-24) Maternal FUT2 Secretor Phenotype Is Associated With Human Milk Oligosaccharides and Polyphenol Metabolites Following a Mediterranean Dietary Intervention: A Pilot Study

Sunday, June 30, 2024

12:45 PM – 1:45 PM CT

Location: Poster Board 528

Presenting Author(s)

Chelsey Fiecke, PhD (she/her/hers)

Postdoctoral Fellow
Arkansas Children's Nutrition Center & University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States

Co-Author(s)

Meghan R. Crimmins, BS (she/her/hers)

PhD Student/ PhD Candidate
Arkansas Children's Nutrition Center, University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
CS

Clark R. Sims, PhD

Assistant Staff Scientist
University of Arkansas for Medical Sciences
LIttle Rock, Arkansas, United States
Lars Bode, PhD

University of California, San Diego
La Jolla, California, United States
Audrey Martinez, PhD(c), MS, RD, LD (she/her/hers)

Research Manager
Arkansas Children's Hospital
Little Rock, Arkansas, United States
MF

Mario G. Ferruzzi

Arkansas Children's Nutrition Center & University of Arkansas for Medical Sciences, Arkansas, United States
Aline Andres, PhD, RD (she/her/hers)

Professor of Pediatrics
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States

Disclosure(s):

Chelsey Fiecke, PhD: No relevant financial relationship(s) with ineligible companies to disclose.

Meghan R. Crimmins, BS: No relevant financial relationship(s) with ineligible companies to disclose.

Audrey Martinez, PhD(c), MS, RD, LD: No relevant financial relationship(s) with ineligible companies to disclose.

Objectives: Extensive variability in human milk (HM) bioactive composition exists between women, even with similar diets, highlighting the complexity of factors modulating HM bioactive profiles. The objective of this study was to carry out a secondary analysis to explore relationships between maternal FUT2 secretor phenotype, diet and HM bioactive profiles (oligosaccharides [HMOs] and polyphenol metabolites) within the context of a Mediterranean dietary intervention.

Methods: In this pilot study, 16 exclusively breastfeeding women with obesity (body mass index (BMI) ≥ 30 kg/m²) enrolled between 4 and 5 mo postpartum and were provided a 4-wk meal plan modeled on the Mediterranean diet. HM was collected for 24 hr at baseline and post-intervention. 13 mother-infant dyads completed the study. Maternal FUT2 secretor phenotype was determined by 2’-fucosyllactose concentration in HM ( < 100 nmol/ml, non-secretor). Concentrations of 19 HMOs and 16 polyphenol metabolites were determined by HPLC and UPLC-MS/MS, respectively.

Results: The change in human milk content of HMOs lacto-N-tetraose (LNT, p = 0.008), lacto-N-fucopentaose II (LNFP II, p = 0.05), LNFP III (p = 0.07), difucosyllacto-N-tetraose (DFLNT, p = 0.10), disialyllacto-N-tetraose (DSLNT, p = 0.01), and microbial-derived polyphenol metabolites 4-hydroxybenzoic acid (4-HBA, p = 0.10), ferulic acid (FA, p = 0.09), and hydroxyphenylpropionic acids (OH-PPAs, p = 0.04) over the intervention time frame was differentially associated with maternal secretor status. An interaction between time and maternal secretor status was observed for LNT (p = 0.01), LNFP II (p = 0.01), DSLNT (p = 0.004), and FA (p = 0.09). Increased concentrations of LNT, DSLNT, 4-HBA, and FA for secretors as well as decreased concentrations of LNT, LNFP II, LNFP III, DFLNT, and OH-PPAs for non-secretors were observed over the 4-week intervention.

Conclusions: The influence of maternal diet on HM bioactive composition differs based on maternal secretor status. Consideration of non-dietary factors is needed to link maternal diet to modification of HM bioactive composition.

Funding Sources: USDA ARS #6026-51000-010-05S and #6026-51000-012-06S, NIH/NIDDK R01DK107516, Arkansas Children’s Research Institute/Arkansas Biosciences Institute GR037121